Latent tuberculosis infection: the final frontier of tuberculosis elimination in the USA

The Lancet Infectious Diseases
Philip A LoBue, Jonathan H Mermin

Abstract

Since 1989, the USA has been pursuing the goal of tuberculosis elimination. After substantial progress during the past two decades, the rate of tuberculosis cases in the USA each year has now levelled off and remains well above the elimination threshold. Both epidemiological data and modelling underline the necessity of addressing latent tuberculosis infection if further progress is to be made in eliminating the disease. In this Personal View we explore next steps towards elimination. Given the estimated prevalence of latent tuberculosis infection, compared with the limited testing and treatment that currently occur, a major new effort is required. This effort should consist of a surveillance system or registry to monitor progress, scale-up of targeted testing for latent tuberculosis infection in at-risk populations, scale-up of short-course treatment regimens, engagement of affected communities and medical providers who serve those communities, and increased public health staffing for implementation and oversight. Such an effort would benefit greatly from the development of new tools, such as tests that better indicate reactivation risk, and even shorter latent tuberculosis infection treatment regimens than currently exist.

Citations

Nov 11, 2017·American Journal of Epidemiology·Jennifer Sanderson SlutskerShama Desai Ahuja
Jun 15, 2018·Respirology : Official Journal of the Asian Pacific Society of Respirology·Cynthia B E CheeRobert Belknap
Jan 17, 2019·American Journal of Public Health·Julie Higashi, Pennan Barry
Apr 24, 2019·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Thitipong MongkolrattanothaiCarla A Winston
Mar 12, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Shereen Katrak, Pennan Barry
Jun 9, 2019·Journal of Clinical Medicine·Meng-Rui LeeInn-Wen Chong
Oct 27, 2018·BMJ Global Health·Patrick K MoonanSunil D Khaparde
Jul 26, 2019·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Lynn E SosaRobert Belknap
Nov 26, 2019·Epidemiology·Maryam B HaddadCarla A Winston
Nov 26, 2019·American Journal of Respiratory and Critical Care Medicine·Andrew Vernon, William Bishai
Aug 30, 2019·Journal of Clinical Microbiology·Thara K VenkatappaChristine S Ho
Jun 26, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Youngji JoDavid Dowdy
Sep 7, 2018·Journal of the Pediatric Infectious Diseases Society·Alexandra Duque-SilvaPennan M Barry
Nov 2, 2018·American Journal of Public Health·Shareen A IqbalThomas R Navin
Mar 29, 2020·The Journal of International Medical Research·Zhangli PengHong Zhang
Sep 12, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Michelle K HaasRobert W Belknap
Jul 31, 2020·Annals of the American Thoracic Society·Yecai LiuMartin S Cetron
Nov 10, 2020·PloS One·John P BonnewellJason E Stout
Nov 27, 2020·International Journal of Molecular Sciences·André CampaniçoFrancisca Lopes
Oct 3, 2019·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Matthew B Schabath, Michele L Cote
Nov 17, 2020·Frontiers in Microbiology·Yuan LiuZhiqiang Wang
Mar 9, 2021·Annals of the American Thoracic Society·James D MancusoAndrew N Hill
Jan 7, 2020·The American Journal of Emergency Medicine·Brit LongMichael Gottlieb
Apr 2, 2021·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Bing-Jie ShenHsien-Ho Lin
Apr 9, 2021·The Journal of Applied Laboratory Medicine·Ghaith AltawallbehAnthony A Killeen
Nov 3, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jeffrey M CollinsUNKNOWN Tuberculosis Epidemiologic Studies Consortium
May 20, 2021·Epidemiology and Infection·Shui Shan LeeJoseph Kai Man Kam
Jun 27, 2021·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Birger TrollforsAnna Dahlgren-Aronsson
Dec 1, 2021·Immunity, Inflammation and Disease·Taosheng YeJinpei Li
Jan 2, 2020·Pediatrics·Amina AhmedUNKNOWN TUBERCULOSIS EPIDEMIOLOGIC STUDIES CONSORTIUM
Jan 5, 2022·Journal of Mathematical Biology·Marissa RenardyMarisa Eisenberg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Related Papers

Revista de igienă, bacteriologie, virusologie, parazitologie, epidemiologie, pneumoftiziologie. Pneumoftiziologia
W Fox
Enfermedades infecciosas y microbiología clínica
William J Burman
© 2022 Meta ULC. All rights reserved